63
Growth Score
pts
Heat Score
-21 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
2237246
Cann10 is an international pharmaceutical company specializing in the field of medical cannabis.
- Yael Meir: COO
- Yossi Bornstein: Founder and DirectorPast Role: Trialog Clinical Trials, Founder
About the Company
Cann10 is an international pharmaceutical company specializing in the field of medical cannabis. The company extensive network of educational and research resources includes major medical institutions, universities and agricultural centers, experience, expertise and know-how of global trade in Israel, Brazil, Australia, and Europe. It holds a
unique ability to support all professionals and business know-how in the Medical Cannabis Value chain.
Cann10 was founded in 2015 and is headquartered in Rosh HaAyin, Israel.
